Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year updateAngela Dispenzieri, Soon-Chai Low, Ivaylo Tarnev et al.|Orphanet Journal of Rare Diseases|2022Cited by 91
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin AmyloidosisAngelo Giuseppe Caponetti, D. Eric Steidley, Claudio Rapezzi et al.|JACC Heart Failure|2021Cited by 80
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes SurveyJosé Nativi-Nicolau, D. Eric Steidley, Alfonso Siu et al.|JACC CardioOncology|2021Cited by 61
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Márcia Waddington‐Cruz, Daniel J. Lenihan, Jonas Wixner et al.|Neurology and Therapy|2021Cited by 48
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes SurveyJuan González‐Moreno, Dianna Quan, Angela Dispenzieri et al.|Cardiology and Therapy|2023Cited by 24